|
KPNA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.166400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.774330E-02 |
| Normal-vs-Stage2 |
2.051800E-01 |
| Normal-vs-Stage3 |
2.590400E-02 |
| Normal-vs-Stage4 |
4.886500E-02 |
| Stage1-vs-Stage2 |
2.268800E-01 |
| Stage1-vs-Stage3 |
9.080400E-01 |
| Stage1-vs-Stage4 |
8.973200E-01 |
| Stage2-vs-Stage3 |
2.847000E-01 |
| Stage2-vs-Stage4 |
3.451600E-01 |
| Stage3-vs-Stage4 |
9.744000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.677100E-03 |
| Normal-vs-AfricanAmerican |
1.510580E-01 |
| Normal-vs-Asian |
1.538570E-01 |
| Caucasian-vs-AfricanAmerican |
4.234800E-01 |
| Caucasian-vs-Asian |
1.842000E-01 |
| AfricanAmerican-vs-Asian |
8.535000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.331650E-01 |
| Normal-vs-Female |
1.187990E-02 |
| Male-vs-Female |
8.872200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021780E-02 |
| Normal-vs-Age(41-60Yrs) |
1.731410E-01 |
| Normal-vs-Age(61-80Yrs) |
1.968370E-02 |
| Normal-vs-Age(81-100Yrs) |
2.612400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.594360E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.278170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.018440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.309740E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.122770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.472600E-01 |
| Classical-VS-Follicular |
2.0224999452978E-10 |
| Classical-VS-Other |
1.508330E-02 |
| Classical-VS-Normal |
2.319700E-03 |
| Tall-VS-Follicular |
1.617220E-03 |
| Tall-VS-Other |
4.742500E-02 |
| Tall-VS-Normal |
2.144200E-02 |
| Follicular-VS-Other |
5.655000E-01 |
| Follicular-VS-Normal |
6.718200E-01 |
| Other-VS-Normal |
5.857200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.212100E-02 |
| Normal-vs-N1 |
1.340200E-01 |
| N0-vs-N1 |
9.543400E-01 |
|
|
